Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Express Scripts
Boehringer Ingelheim
Medtronic
Merck

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2018)

Docket   Start Trial Date Filed 2018-05-08
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To
Jury Demand Referred To
Parties AMNEAL PHARMACEUTICALS LLC; HISAMITSU PHARMACEUTICAL CO. INC.; NOVEN PHARMACEUTICALS, INC.
Patents 9,724,310; 9,730,900; 9,833,419
Attorneys Andrew Colin Mayo; Anne Shea Gaza; Jeremy J. Edwards; John G. Day; Kaveh Saba; Matthew C. Ruedy; Samantha G. Wilson; Steven A. Maddox
Firms Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2019-03-08 112 Opinion - Memorandum Opinion infringement of U.S. Patent Nos. 9,730,900 (the "' 900 Patent"), 9,724,310 (the '"…310 Patent"), and 9,833 ,419 (the '" 419 Patent") (collectively, "patents-in-…-suit" or "asserted patents"). (D.I. 83 at 3) The patents-in-suit relate "to transdermal…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent "specification External link to document
2019-10-24 172 Order - -Memorandum and Order regarding noninfringement of U.S. Patent No. 9,833 ,419 ("the '419 patent"), is DENIED. It does…theory of infringement in connection with related patent after trial) . 5. Defendant' s… 8 May 2018 1:18-cv-00699-LPS Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Mallinckrodt
McKinsey
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.